EBITDA Margin (Annual)

EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues

Bio-Rad Laboratories, Inc. (BIO.B) had EBITDA Margin of 1.83% for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$2.58B
Net Income	$759.90M
Cost of Goods Sold	$1.24B
Gross Profit	$1.34B
Operating Expenses	$2.54B
Operating Income	$47.20M
Non-Operating Income/Expense	$948.30M
Pre-Tax Income	$995.50M
Normalized Pre-Tax Income	$95.10M
Income after Taxes	$759.90M
Income from Continuous Operations	$759.90M
Consolidated Net Income/Loss	$759.90M
Normalized Income after Taxes	$-353.59M
EBIT	$47.20M
EBITDA	$47.20M
Weighted-Average Shares Outstanding (Basic)	27.26M
Weighted-Average Shares Outstanding (Diluted)	27.28M
Earnings per Share (EPS) (Basic)	$27.87
Earnings per Share (EPS) (Diluted)	$27.85
Balance Sheet Financials
Current Assets	$2.91B
Property, Plant, and Equipment	$539.90M
Long-Term Assets	$7.67B
Total Assets	$10.58B
Current Liabilities	$517.00M
Long-Term Debt	$1.20B
Long-Term Liabilities	$2.61B
Total Liabilities	$3.12B
Common Equity	$7.45B
Tangible Shareholders Equity	$6.70B
Shareholders Equity	$7.45B
Common Shares Outstanding	26.99M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$532.20M
Cash Flow from Investing Activities	$-189.70M
Cash Flow from Financial Activities	$-283.20M
Beginning Cash	$489.80M
End Cash	$532.20M
Increase/Decrease in Cash	$42.40M
Stock-Based Compensation	--
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	5.62
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.14
Debt to Equity Ratio	0.16
Gross Margin	51.87%
Operating Margin	1.83%
EBIT Margin	1.83%
EBITDA Margin	1.83%
Pre-Tax Profit Margin	38.54%
Profit Margin	29.42%
Free Cash Flow	$374.70M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.24
Inventory Turnover	1.68
Receiveable Turnover	5.61
Days Sales in Receivables	65.08
Return on Equity	10.20%
Return on Tangible Equity	11.34%
Return on Assets	7.18%
Return on Investments	8.78%
Book Value Per Share	$276.16
Free Cash Flow per Share	$13.73
Operating Cash Flow per Share	$19.51

Data from Zacks Investment Research, Inc.